Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.54 |
| ▸ | PNMT | P11086 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | TDO2 | P48775 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | S100B | P04271 | 1/20 | 0.37 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.37 |
| ▸ | ITGAV | P06756 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.36 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19856483 | 0.83 | CYP1A2 (0.56) | CYP1A2PNMTCYP3A4CYP2D6NFKB1 | |
| SCHEMBL456765 | 0.80 | ADRB2 (0.47) | CYP3A4CYP2D6NFKB1ALDH1A1LMNA | |
| SCHEMBL1872442 | 0.80 | CYP1A2 (0.58) | CYP1A2PNMTCYP3A4CYP2D6NFKB1 | |
| SCHEMBL7546175 | 0.79 | CYP1A2 (0.63) | CYP1A2PNMTCYP3A4CYP2D6NFKB1 | |
| SCHEMBL8519506 | 0.78 | ADRB2 (0.46) | CYP3A4CYP2D6NFKB1ALDH1A1LMNA | |
| SCHEMBL5742922 | 0.77 | CYP2D6 (0.50) | CYP1A2PNMTCYP3A4CYP2D6NFKB1 | |
| SCHEMBL5617277 | 0.76 | PNMT (0.54) | CYP1A2PNMTCYP3A4CYP2D6NFKB1 | |
| SCHEMBL5614982 | 0.76 | PNMT (0.54) | CYP1A2PNMTCYP3A4CYP2D6NFKB1 | |
| SCHEMBL5614873 | 0.76 | PNMT (0.54) | CYP1A2PNMTCYP3A4CYP2D6NFKB1 | |
| SCHEMBL9409630 | 0.76 | PNMT (0.54) | CYP1A2PNMTCYP3A4CYP2D6NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108745222-B | Anti-sedimentation type microreactor and synthesis system | 华北电力大学 | 2023-09-01 | — | — | CN | disclosed |
| US-20080004387-A1 | Alkyl benzyl esters of polycarboxylic acids | LANXESS DEUTSCHLAND GMBH (DE) | 2008-01-03 | — | — | US | disclosed |
| US-7105500-B2 | Process for the antimicrobial treatment of fiber materials | CIBA SPECIALTY CHEMICALS CORP. (US) | 2006-09-12 | — | — | US | disclosed |
| US-20050080044-A1 | Process for the antimicrobial treatment of fiber materials | HUNTSMAN INTERNATIONAL LLC | 2005-04-14 | — | — | US | disclosed |
| EP-1319102-A1 | PROCESS FOR THE ANTIMICROBIAL TREATMENT OF FIBER MATERIALS | Ciba SC Holding AG (CH) | 2003-06-18 | — | — | EP | disclosed |
| EP-1201229-A1 | Concentrated liquid formulations comprising a microbicidally active ingredient | Ciba SC Holding AG (CH) | 2002-05-02 | — | — | EP | disclosed |
| WO-2002022941-A1 | PROCESS FOR THE ANTIMICROBIAL TREATMENT OF FIBER MATERIALS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-03-21 | — | — | WO | disclosed |
| US-6358906-B1 | CHLORINATED AND/OR BROMINATED 2-HYDROXYDIPHENYL ETHER DERIVATIVE; ALCOHOL, SULFONATE, CARBOXYLIC ACID AND WATER; HAND SOAP | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-03-19 | — | — | US | disclosed |
| US-6346125-B1 | TREATING NONWOVEN WITH AQUEOUS COMPOSITION COMPRISING ANTIMICROBIAL HALOGENO-O-HYDROXYDIPHENYL, SOLUBILIZER FOR ANTIMICROBIAL, OPTIONAL COPOLYMER OF MONOMER HAVING AFFINITY TO TEXTILES AND MONOMER HAVING AFFINITY FOR ANTIMICROBIAL | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-02-12 | — | — | US | disclosed |
| US-20010055651-A1 | PROCESS FOR THE TREATMENT OF TEXTILE MATERIALS WITH AN ANTIMICROBIAL AGENT | CIBA SPECIALTY CHEMICALS CORP. | 2001-12-27 | — | — | US | disclosed |
| EP-1141453-A1 | INCORPORATION OF ORGANIC ANTI-MICROBIALS INTO FIBRES DURING A FIBRE SPINNING PROCESS | Ciba SC Holding AG (CH) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000026447-A1 | INCORPORATION OF ORGANIC ANTI-MICROBIALS INTO FIBRES DURING A FIBRE SPINNING PROCESS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2000-05-11 | — | — | WO | disclosed |
| EP-0937812-A2 | Process for the treatment of nonwovens with antimicrobial agents | Ciba SC Holding AG (CH) | 1999-08-25 | — | — | EP | disclosed |
| EP-0914085-A2 | CONCENTRATED LIQUID ACCUMULATIONS COMPRISING A MICROBICIDALLY ACTIVE INGREDIENT | Ciba SC Holding AG (CH) | 1999-05-12 | — | — | EP | disclosed |
| EP-0908553-A2 | Process for the treatment of textile materials with an antimicrobial agent | Ciba SC Holding AG (CH) | 1999-04-14 | — | — | EP | disclosed |
| WO-1997046218-A2 | CONCENTRATED LIQUID FORMULATIONS COMPRISING A MICROBICIDALLY ACTIVE INGREDIENT | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1997-12-11 | — | — | WO | disclosed |
| EP-0777717-A2 | SURFACE-ACTIVE FORMULATIONS | Ciba SC Holding AG (CH) | 1997-06-11 | — | — | EP | disclosed |
| WO-1996006153-A2 | SURFACE-ACTIVE FORMULATIONS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1996-02-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080044-A1 | Process for the antimicrobial treatment of fiber materials | NOD2, AAAS, C9 | CYP1A2 3170/4885PNMT 1065/4885CYP3A4 1804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.